Cargando…

AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response

Lipopolysaccharides (LPS) are major outer membrane components of Gram-negative bacteria and produce strong inflammatory responses in animals. Most antibiotics have shown little clinical anti-endotoxin activity while some antimicrobial peptides have proved to be effective in blocking LPS. Here, the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiuyu, Jin, Lili, Wang, Huan, Tai, Sijia, Liu, Hongsheng, Zhang, Dianbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855822/
https://www.ncbi.nlm.nih.gov/pubmed/29463000
http://dx.doi.org/10.3390/ijms19020600
_version_ 1783307187707183104
author Wang, Qiuyu
Jin, Lili
Wang, Huan
Tai, Sijia
Liu, Hongsheng
Zhang, Dianbao
author_facet Wang, Qiuyu
Jin, Lili
Wang, Huan
Tai, Sijia
Liu, Hongsheng
Zhang, Dianbao
author_sort Wang, Qiuyu
collection PubMed
description Lipopolysaccharides (LPS) are major outer membrane components of Gram-negative bacteria and produce strong inflammatory responses in animals. Most antibiotics have shown little clinical anti-endotoxin activity while some antimicrobial peptides have proved to be effective in blocking LPS. Here, the anti-LPS activity of the synthetic peptide AWRK6, which is derived from antimicrobial peptide dybowskin-2CDYa, has been investigated in vitro and in vivo. The positively charged α-helical AWRK6 was found to be effective in blocking the binding of LBP (LPS binding protein) with LPS in vitro using ELISA. In a murine endotoxemia model, AWRK6 offered satisfactory protection efficiency against endotoxemia death, and the serum levels of LPS, IL-1β, IL-6, and TNF-α were found to be attenuated using ELISA. Further, histopathological analysis suggested that AWRK6 could improve the healing of liver and lung injury in endotoxemia mice. The results of real-time PCR and Western blotting showed that AWRK6 significantly reversed LPS-induced TLR4 overexpression and IκB depression, as well as the enhanced IκB phosphorylation. Additionally, AWRK6 did not produce any significant toxicity in vivo and in vitro. In summary, AWRK6 showed efficacious protection from LPS challenges in vivo and in vitro, by blocking LPS binding to LBP, without obvious toxicity, providing a promising strategy against LPS-induced inflammatory responses.
format Online
Article
Text
id pubmed-5855822
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-58558222018-03-20 AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response Wang, Qiuyu Jin, Lili Wang, Huan Tai, Sijia Liu, Hongsheng Zhang, Dianbao Int J Mol Sci Article Lipopolysaccharides (LPS) are major outer membrane components of Gram-negative bacteria and produce strong inflammatory responses in animals. Most antibiotics have shown little clinical anti-endotoxin activity while some antimicrobial peptides have proved to be effective in blocking LPS. Here, the anti-LPS activity of the synthetic peptide AWRK6, which is derived from antimicrobial peptide dybowskin-2CDYa, has been investigated in vitro and in vivo. The positively charged α-helical AWRK6 was found to be effective in blocking the binding of LBP (LPS binding protein) with LPS in vitro using ELISA. In a murine endotoxemia model, AWRK6 offered satisfactory protection efficiency against endotoxemia death, and the serum levels of LPS, IL-1β, IL-6, and TNF-α were found to be attenuated using ELISA. Further, histopathological analysis suggested that AWRK6 could improve the healing of liver and lung injury in endotoxemia mice. The results of real-time PCR and Western blotting showed that AWRK6 significantly reversed LPS-induced TLR4 overexpression and IκB depression, as well as the enhanced IκB phosphorylation. Additionally, AWRK6 did not produce any significant toxicity in vivo and in vitro. In summary, AWRK6 showed efficacious protection from LPS challenges in vivo and in vitro, by blocking LPS binding to LBP, without obvious toxicity, providing a promising strategy against LPS-induced inflammatory responses. MDPI 2018-02-17 /pmc/articles/PMC5855822/ /pubmed/29463000 http://dx.doi.org/10.3390/ijms19020600 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Qiuyu
Jin, Lili
Wang, Huan
Tai, Sijia
Liu, Hongsheng
Zhang, Dianbao
AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response
title AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response
title_full AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response
title_fullStr AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response
title_full_unstemmed AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response
title_short AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response
title_sort awrk6, a synthetic cationic peptide derived from antimicrobial peptide dybowskin-2cdya, inhibits lipopolysaccharide-induced inflammatory response
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855822/
https://www.ncbi.nlm.nih.gov/pubmed/29463000
http://dx.doi.org/10.3390/ijms19020600
work_keys_str_mv AT wangqiuyu awrk6asyntheticcationicpeptidederivedfromantimicrobialpeptidedybowskin2cdyainhibitslipopolysaccharideinducedinflammatoryresponse
AT jinlili awrk6asyntheticcationicpeptidederivedfromantimicrobialpeptidedybowskin2cdyainhibitslipopolysaccharideinducedinflammatoryresponse
AT wanghuan awrk6asyntheticcationicpeptidederivedfromantimicrobialpeptidedybowskin2cdyainhibitslipopolysaccharideinducedinflammatoryresponse
AT taisijia awrk6asyntheticcationicpeptidederivedfromantimicrobialpeptidedybowskin2cdyainhibitslipopolysaccharideinducedinflammatoryresponse
AT liuhongsheng awrk6asyntheticcationicpeptidederivedfromantimicrobialpeptidedybowskin2cdyainhibitslipopolysaccharideinducedinflammatoryresponse
AT zhangdianbao awrk6asyntheticcationicpeptidederivedfromantimicrobialpeptidedybowskin2cdyainhibitslipopolysaccharideinducedinflammatoryresponse